Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Delcath Systems, Inc. (DCTH : NSDQ)
 
 • Company Description   
Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver.

Number of Employees: 96

 
 • Price / Volume Information   
Yesterday's Closing Price: $13.60 Daily Weekly Monthly
20 Day Moving Average: 721,628 shares
Shares Outstanding: 34.83 (millions)
Market Capitalization: $473.64 (millions)
Beta: 0.87
52 Week High: $18.23
52 Week Low: $7.17
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -16.56% -20.18%
12 Week 24.66% 1.70%
Year To Date 12.96% 7.07%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
566 QUEENSBURY AVENUE
-
QUEENSBURY,NY 12804
USA
ph: 518-743-8892
fax: 212-489-2102
investorrelations@delcath.com http://www.delcath.com
 
 • General Corporate Information   
Officers
Gerard Michel - Chief Executive Officer and Director
John R. Sylvester - Chairman of the Board
Sandra Pennell - Chief Financial Officer
Elizabeth Czerepak - Director
Steven Salamon - Director

Peer Information
Delcath Systems, Inc. (ABMD)
Delcath Systems, Inc. (DMDS)
Delcath Systems, Inc. (CPWY.)
Delcath Systems, Inc. (EQUR)
Delcath Systems, Inc. (ECIA)
Delcath Systems, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 24661P807
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/04/25
Share - Related Items
Shares Outstanding: 34.83
Most Recent Split Date: 12.00 (0.00:1)
Beta: 0.87
Market Capitalization: $473.64 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.02 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.33 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 41.21
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 5.67
Price/Cash Flow: -
Price / Sales: 8.80
EPS Growth
vs. Year Ago Period: 106.98%
vs. Previous Quarter: -40.00%
Sales Growth
vs. Year Ago Period: 530.26%
vs. Previous Quarter: 31.02%
ROE
06/30/25 - -
03/31/25 - -29.44
12/31/24 - -97.67
ROA
06/30/25 - -
03/31/25 - -20.75
12/31/24 - -52.67
Current Ratio
06/30/25 - -
03/31/25 - 15.95
12/31/24 - 12.01
Quick Ratio
06/30/25 - -
03/31/25 - 14.61
12/31/24 - 10.88
Operating Margin
06/30/25 - -
03/31/25 - -22.11
12/31/24 - -63.09
Net Margin
06/30/25 - -
03/31/25 - -26.38
12/31/24 - -70.92
Pre-Tax Margin
06/30/25 - -
03/31/25 - -26.02
12/31/24 - -70.92
Book Value
06/30/25 - -
03/31/25 - 2.40
12/31/24 - 2.15
Inventory Turnover
06/30/25 - -
03/31/25 - 1.20
12/31/24 - 1.05
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©